Healthcare provider profile · identity verified

Sumera Younus, M.D.

Family Practice · SAINT LOUIS, MO · NPI 1003962820

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	966	266
Amlodipine Besylate	Amlodipine Besylate	693	191
Rosuvastatin Calcium	Rosuvastatin Calcium	635	190
Levothyroxine Sodium	Levothyroxine Sodium	590	157
Losartan Potassium	Losartan Potassium	584	169
Lisinopril	Lisinopril	330	91
Metoprolol Succinate	Metoprolol Succinate	322	87
Omeprazole	Omeprazole	312	92
Gabapentin	Gabapentin	243	78
Trazodone Hcl	Trazodone Hcl	237	68
Hydrochlorothiazide	Hydrochlorothiazide	218	63
Escitalopram Oxalate	Escitalopram Oxalate	216	64
Metformin Hcl Er	Metformin Hcl	216	65
Pantoprazole Sodium	Pantoprazole Sodium	213	66
Tramadol Hcl	Tramadol Hcl	186	49
Meloxicam	Meloxicam	164	56
Metformin Hcl	Metformin Hcl	159	52
Simvastatin	Simvastatin	155	40
Duloxetine Hcl	Duloxetine Hcl	150	33
Pravastatin Sodium	Pravastatin Sodium	149	42
Zolpidem Tartrate	Zolpidem Tartrate	148	32
Furosemide	Furosemide	141	45
Alprazolam	Alprazolam	139	40
Famotidine	Famotidine	125	42
Potassium Chloride	Potassium Chloride	114	37
Metoprolol Tartrate	Metoprolol Tartrate	113	31
Eliquis	Apixaban	112	30
Alendronate Sodium	Alendronate Sodium	111	34
Sertraline Hcl	Sertraline Hcl	108	33
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	105	30
Allopurinol	Allopurinol	98	29
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	96	28
Ezetimibe	Ezetimibe	91	27
Mirtazapine	Mirtazapine	85	30
Montelukast Sodium	Montelukast Sodium	83	22
Carvedilol	Carvedilol	82	24
Citalopram Hbr	Citalopram Hydrobromide	82	22
Olmesartan Medoxomil	Olmesartan Medoxomil	82	24
Tamsulosin Hcl	Tamsulosin Hcl	82	24
Atenolol	Atenolol	81	24
Arexvy	Rsvpref3 Antigen/As01e/Pf	78	77
Buspirone Hcl	Buspirone Hcl	78	21
Bupropion Xl	Bupropion Hcl	76	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	76	18
Lorazepam	Lorazepam	76	23
Mounjaro	Tirzepatide	76	15
Ozempic	Semaglutide	76	17
Irbesartan	Irbesartan	69	20
Enalapril Maleate	Enalapril Maleate	66	16
Pregabalin	Pregabalin	66	13
Clopidogrel	Clopidogrel Bisulfate	61	17
Fluticasone Propionate	Fluticasone Propionate	61	24
Glipizide Er	Glipizide	59	20
Esomeprazole Magnesium	Esomeprazole Magnesium	56	16
Albuterol Sulfate Hfa	Albuterol Sulfate	54	27
Farxiga	Dapagliflozin Propanediol	53	16
Spironolactone	Spironolactone	53	19
Jardiance	Empagliflozin	52	15
Venlafaxine Hcl Er	Venlafaxine Hcl	52	13
Vitamin D2	Ergocalciferol (Vitamin D2)	52	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	16
Glimepiride	Glimepiride	47	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	47	39
Valacyclovir	Valacyclovir Hcl	47	21
Synthroid	Levothyroxine Sodium	44	13
Amitriptyline Hcl	Amitriptyline Hcl	43	11
Lovastatin	Lovastatin	43	12
Ondansetron Odt	Ondansetron	41	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	40	suppressed
Diazepam	Diazepam	38	19
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Nystatin	Nystatin	38	11
Dilt-Xr	Diltiazem Hcl	37	12
Doxycycline Hyclate	Doxycycline Hyclate	36	30
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	32	29
Valsartan	Valsartan	31	suppressed
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Finasteride	Finasteride	29	11
Lamotrigine	Lamotrigine	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	16
Linzess	Linaclotide	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Tresiba Flextouch U-100	Insulin Degludec	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Celecoxib	Celecoxib	25	suppressed
Methylprednisolone	Methylprednisolone	24	23
Azithromycin	Azithromycin	23	22
Paxlovid	Nirmatrelvir/Ritonavir	23	23
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	19
Myrbetriq	Mirabegron	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Risedronate Sodium	Risedronate Sodium	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Labetalol Hcl	Labetalol Hcl	20	suppressed
Topiramate	Topiramate	20	suppressed
Baclofen	Baclofen	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Methocarbamol	Methocarbamol	19	11
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Tradjenta	Linagliptin	19	suppressed
Travoprost	Travoprost	19	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Temazepam	Temazepam	18	suppressed
Amoxicillin	Amoxicillin	17	13
Chlorthalidone	Chlorthalidone	17	suppressed
Indapamide	Indapamide	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Prednisone	Prednisone	17	14
Torsemide	Torsemide	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Cephalexin	Cephalexin	16	15
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Estradiol	Estradiol	16	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Fenofibrate	Fenofibrate,micronized	15	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	14	suppressed
Ramipril	Ramipril	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Clomipramine Hcl	Clomipramine Hcl	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Methylphenidate Er	Methylphenidate Hcl	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Mupirocin	Mupirocin	11	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error